INTERNATIONAL PATENT: FIDIA FARMACEUTICI S.P.A. FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF DEGENERATION OF THE OPTIC NERVE AND RETINAL NERVE CELLS RESULTING FROM GLAUCOMA"

GENEVA, Jan. 12 -- FIDIA FARMACEUTICI S.P.A. (Via Ponte della Fabbrica, 3/A35031 Abano Terme (PD)) filed a patent application (PCT/IB2025/056791) for "PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF DEGENERATION OF THE OPTIC NERVE AND RETINAL NERVE CELLS RESULTING FROM GLAUCOMA" on Jul 04, 2025. With publication no. WO/2026/009194, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAMPISI, Monica (c/o FIDIA FARMACEUTICI S.P.A.Via Ponte della Fabbrica 3/A35031 Abano Terme (PD)), GENNARI, Giovanni (c/o FIDI...